2561 — Visen Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.73bn
- HK$2.21bn
- CNY0.17m
Annual cashflow statement for Visen Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -289 | -250 | -182 | -253 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 88.7 | 46.6 | 26.2 | 65 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -53.6 | -75.3 | 10.8 | -262 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -247 | -271 | -141 | -448 |
| Capital Expenditures | -1.77 | -0.52 | -0.117 | -2.57 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | — | — | — | 9.24 |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | -1.77 | -0.52 | -0.117 | 6.67 |
| Financing Cash Flow Items | -2.17 | -2.01 | 0 | -21.2 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -7.95 | -6.95 | -3.09 | 870 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -256 | -279 | -144 | 429 |